GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $80,000 | -99.8% | 369 | -99.9% | 0.00% | -100.0% |
| Q4 2020 | $37,659,000 | +25.5% | 326,307 | +5.9% | 0.02% | +9.5% |
| Q3 2020 | $29,998,000 | -20.7% | 308,143 | +0.0% | 0.02% | -27.6% |
| Q2 2020 | $37,815,000 | +56.1% | 308,141 | +11.4% | 0.03% | +31.8% |
| Q1 2020 | $24,228,000 | -23.2% | 276,678 | -8.3% | 0.02% | +4.8% |
| Q4 2019 | $31,558,000 | -22.0% | 301,839 | -14.2% | 0.02% | -25.0% |
| Q3 2019 | $40,445,000 | -19.2% | 351,615 | +21.1% | 0.03% | -3.4% |
| Q2 2019 | $50,051,000 | +16.4% | 290,342 | +13.9% | 0.03% | +11.5% |
| Q1 2019 | $42,983,000 | +63.1% | 255,003 | -5.8% | 0.03% | +36.8% |
| Q4 2018 | $26,350,000 | -67.0% | 270,575 | -41.4% | 0.02% | -17.4% |
| Q3 2018 | $79,769,000 | -14.5% | 461,788 | -30.9% | 0.02% | -14.8% |
| Q2 2018 | $93,253,000 | +206.5% | 668,299 | +147.5% | 0.03% | +80.0% |
| Q1 2018 | $30,426,000 | +1.0% | 270,057 | +18.3% | 0.02% | -21.1% |
| Q4 2017 | $30,124,000 | +333.9% | 228,206 | +233.5% | 0.02% | +280.0% |
| Q3 2017 | $6,942,000 | -53.2% | 68,423 | -53.8% | 0.01% | -54.5% |
| Q2 2017 | $14,848,000 | -35.0% | 148,133 | -21.6% | 0.01% | -35.3% |
| Q1 2017 | $22,835,000 | +15.8% | 188,829 | +7.0% | 0.02% | +6.2% |
| Q4 2016 | $19,725,000 | +42.6% | 176,527 | +69.4% | 0.02% | +60.0% |
| Q3 2016 | $13,828,000 | +78.7% | 104,194 | +23.3% | 0.01% | +100.0% |
| Q2 2016 | $7,736,000 | +153.2% | 84,499 | +99.5% | 0.01% | +150.0% |
| Q1 2016 | $3,055,000 | -44.3% | 42,364 | -46.3% | 0.00% | -50.0% |
| Q4 2015 | $5,482,000 | +774.3% | 78,961 | +1048.9% | 0.00% | – |
| Q3 2015 | $627,000 | +6.5% | 6,873 | +43.1% | 0.00% | – |
| Q2 2015 | $589,000 | -2.2% | 4,804 | -27.5% | 0.00% | – |
| Q1 2015 | $602,000 | +225.4% | 6,623 | +141.2% | 0.00% | – |
| Q4 2014 | $185,000 | +131.2% | 2,746 | +174.6% | 0.00% | – |
| Q3 2014 | $80,000 | -31.0% | 1,000 | -8.4% | 0.00% | – |
| Q2 2014 | $116,000 | -87.5% | 1,092 | -93.0% | 0.00% | -100.0% |
| Q1 2014 | $931,000 | – | 15,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |